While at Lederle Labs (now Pfizer), he did clinical research, held sales & marketing positions in the drug & diagnostic divisions, managed marketing & sales people. He has 5 years in pre-clinical drug development & is applies these skills to develop ARIZ drugs. He licensed technology from universities, cancer centers & biotech companies & licensed drugs to pharma companies, all tasks similar to the licensing objectives of ARIZ Precision Medicine.

He has 15 years of experience in cancer research & has published 12 scientific papers. In addition, he has managed product development projects for two different biotech startups & served as a mentor for multiple student-led business competition teams. He is the Principal Investigator on two Small Business Innovative Research Grants submitted to the National Cancer Institute. He organized the proof of concept studies in animal models of cancer.

Mr. Hooper has been involved in the biotechnology industry from the beginning (in early 1980) having joined Genentech at that time. While there he served in several management positions, including Senior Director, Business Development. He was involved in corporate development wearing many 'hats'. Gary also has senior executive and experience in IPOs (Cyngus), large strategic agreements (Genencor & Dow) and as the CEO in four start-up companies.

She served as Executive Director of a Business Accelerator in Davis, was a founding & managing partner at The Centaur Group. She was V.P. & Officer at a Sacramento insurance agency. She served on the Boards of the Yolo Food Bank & Davis Schools Foundation. She was an impactful committee member for Designing a Sustainable and Innovative Davis Economy. Her contacts and depth in the locoregional business community is key to her fund raising efforts.